Table 2.

Unadjusted discontinuation outcomes.

	Fingolimod (N = 271)		Dimethyl fumarate (N = 342)
	N or mean	% or SD	N or mean	% or SD	p value
Discontinued drug ≤24 months	93	34.3%	161	47.1%	0.001
Disease activitya	27	10.0%	38	11.1%	0.647
Adverse events	46	17.0%	82	24.0%	0.034
Insurance	2	0.7%	4	1.2%	0.699
Lost to follow-up	15	5.5%	27	7.9%	0.251
Other	3	1.1%	10	2.9%	0.161
Mean time to discontinuation (months)b	10.3	7.1	10.0	7.2	0.539

^aIncludes discontinuation of drug because of clinical relapse, magnetic resonance imaging activity or disease progression.

^bFor those who discontinue.